These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 24123036)

  • 1. Prevalence of H. pylori infection and atrophic gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital-based screening study using a panel of serum biomarkers.
    Benberin V; Bektayeva R; Karabayeva R; Lebedev A; Akemeyeva K; Paloheimo L; Syrjänen K
    Anticancer Res; 2013 Oct; 33(10):4595-602. PubMed ID: 24123036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg.
    Roman LD; Lukyanchuk R; Sablin OA; Araslanova EI; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
    Anticancer Res; 2016 Aug; 36(8):4129-38. PubMed ID: 27466521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care.
    Germaná B; Di Mario F; Cavallaro LG; Moussa AM; Lecis P; Liatoupolou S; Comparato G; Carloni C; Bertiato G; Battiestel M; Papa N; Aragona G; Cavestro GM; Iori V; Merli R; Bertolini S; Caruana P; Franzé A
    Dig Liver Dis; 2005 Jul; 37(7):501-8. PubMed ID: 15975537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and
    Koivurova OP; Koskela R; Blomster T; Ala-Rämi A; Lumme H; Kettunen O; Hukkanen J; Karttunen TJ; Mäkinen M; Ronkainen J; Syrjänen K
    Anticancer Res; 2021 Nov; 41(11):5527-5537. PubMed ID: 34732423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia.
    Leja M; Cine E; Rudzite D; Vilkoite I; Huttunen T; Daugule I; Rumba-Rozenfelde I; Pimanov S; Liepniece-Karele I; Pahomova J; Purmalis K; Eglitis J; Pirags V; Dzerve V; Erglis A
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1410-7. PubMed ID: 23114744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GastroPanel® test for non-invasive diagnosis of atrophic gastritis in patients with dyspepsia.
    Masci E; Pellicano R; Mangiavillano B; Luigiano C; Stelitano L; Morace C; Viale E; Freschi M; Locatelli M; Ieri R; Cavallaro A; Testoni S; Testoni PA
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):79-83. PubMed ID: 24632770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk of gastric cancer dependent on serological markers of atrophic gastritis: cohort study].
    Reshetnikov OV; Openko TG; Simonova GI; Kurilovich SA; Maliushina SK; Ragino IuI; Voevoda MI
    Vopr Onkol; 2012; 58(5):644-8. PubMed ID: 23600281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies.
    Hartleb M; Wandzel P; Waluga M; Matyszczyk B; Bołdys H; Romañczyk T
    Acta Gastroenterol Belg; 2004; 67(4):320-6. PubMed ID: 15727075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q; Ran ZH; Xiao SD
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are the serum biomarkers pepsinogen I and II good predictors for the detection of subjects with atrophic gastritis in areas that have different gastric cancer incidence?
    Mohamadkhani A; Darvish Moghaddam S; Salmanroghani H; Allafsghari A; Yazdanbod A; Mirzaei M; Haj-sheykholeslami A; Bashiri J; Sadjadi A; Massarrat S
    Arch Iran Med; 2013 Apr; 16(4):208-12. PubMed ID: 23496362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori.
    Ricci C; Vakil N; Rugge M; Gatta L; Perna F; Osborn JF; Russo VM; Tampieri A; Bernabucci V; Miglioli M; Vaira D
    Am J Gastroenterol; 2004 Oct; 99(10):1910-5. PubMed ID: 15447749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
    Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori infection and atrophic gastritis.
    Ebule IA; Longdoh AN; Paloheimo IL
    Afr Health Sci; 2013 Mar; 13(1):112-7. PubMed ID: 23658576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers.
    Agréus L; Kuipers EJ; Kupcinskas L; Malfertheiner P; Di Mario F; Leja M; Mahachai V; Yaron N; van Oijen M; Perez Perez G; Rugge M; Ronkainen J; Salaspuro M; Sipponen P; Sugano K; Sung J
    Scand J Gastroenterol; 2012 Feb; 47(2):136-47. PubMed ID: 22242613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
    Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
    Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study.
    Storskrubb T; Aro P; Ronkainen J; Sipponen P; Nyhlin H; Talley NJ; Engstrand L; Stolte M; Vieth M; Walker M; Agréus L
    Scand J Gastroenterol; 2008; 43(12):1448-55. PubMed ID: 18663663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
    Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.